-

Ephicacy Bolsters Leadership Team with Four New Hires

ISELIN, N.J.--(BUSINESS WIRE)--Ephicacy Consulting Group, Inc., (“Ephicacy”), a leading biometrics Contract Research Organization (“CRO”) and global provider of statistical programming, biostatistics, data management and real-world evidence analytics services, today announced four senior leadership appointments that further position the company for continued growth.

Executive Leadership Appointments:

  • Jim Baker as Chief Operating Officer, to oversee operations across client engagement and business development for the global company. Jim brings over 35 years of experience leading bioanalytical teams at CROs and pharmaceutical companies, including at Cytel, Takeda and Amgen. His role will be critical in ensuring quality, driving efficiencies, and streamlining growth.
  • Sukhvinder Singh as Chief Financial Officer, to lead Ephicacy’s financial management and FP&A functions. Sukhvinder brings over 30 years of experience in global financial management and operations. Previously, Sukhvinder was CFO of another biostatistics CRO, GCE Solutions, and most recently he served as CFO of Lotus Clinical Research. Sukhvinder’s diverse experience will strengthen Ephicacy’s financial controls globally.
  • Ioana Mihalache as Chief People Officer, to drive alignment of Ephicacy’s global talent strategy and foster a growth-oriented culture. Ioana has extensive experience in leadership development and a proven track record of successfully implementing effective HR operating models, most recently in her role as Global HR Lead at Genpact. Ioana will be integral to the team’s success in continuing to foster a collaborative culture with an emphasis on growth.
  • Dr. Santhosh Kumar as Head of India and Global Delivery, to manage Ephicacy’s operations and people across India and continue expanding its global delivery reach. Santhosh brings over 20 years of experience in clinical data services across multiple geographies. Santhosh previously held leadership roles at large industry competitors, including IQVIA and Accenture. Santhosh’s role will enhance interconnectivity across Ephicacy’s global team and customer base.

“We are pleased to welcome these outstanding leaders as we continue to strengthen our global capabilities and expand the reach of services we offer to our customers,” said Ganesh Gopal, CEO of Ephicacy. “Our recent growth and continued global expansion has broadened our employee and customer base, and we look forward to leveraging our management team’s deep expertise to continue providing best-in-class services for our partners.”

“Ephicacy’s considerable growth in recent years has unlocked exciting new opportunities,” said Jim Baker, Ephicacy’s new Chief Operating Officer. “I look forward to working alongside the talented team to build on this momentum, drawing on my experience helping CROs expand and scale at important moments in their lifecycle.”

About Ephicacy Consulting Group, Inc.

Headquartered in Iselin, NJ, with employees and operations across North America and India, Ephicacy is a rapidly growing biometrics CRO, providing outsourced statistical programming, biostatistics, data management, and real-world evidence analytics services to pharmaceutical and biotechnology companies. Since its founding in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool of ~500 resources to help global pharmaceutical and biotechnology companies reduce their time to market in a cost-effective manner. More information on the Company and its services can be viewed online at www.ephicacy.com

Contacts

Media Contact
Prosek Partners
Pro-gpp@prosek.com

Ephicacy Consulting Group, Inc.


Release Summary
Ephicacy Consulting Group, Inc., today announced four senior leadership appointments that further position the company for continued growth.
Release Versions

Contacts

Media Contact
Prosek Partners
Pro-gpp@prosek.com

More News From Ephicacy Consulting Group, Inc.

Great Point Partners Acquires a Majority Stake in Lenis Group, a Full-Service Specialty Pharmaceutical Commercialization and Distribution Partner

GREENWICH, Conn. & LJUBLJANA, Slovenia--(BUSINESS WIRE)--Great Point Partners (“GPP” or “the Firm”), a Greenwich-based private investment firm focused exclusively on the healthcare industry, today announced that it has acquired a majority stake in Lenis Group (“Lenis” or “the Company”), a fast-growing Slovenian-based full-service regional commercialization and distribution partner for niche and specialty Rx medicines in Central and Eastern Europe (“CEE”). Founded in 2008, Lenis has become a tru...

Great Point Partners Named to Inc.’s 2025 List of Founder-Friendly Investors for Third Consecutive Year

GREENWICH, Conn.--(BUSINESS WIRE)--Great Point Partners, (“Great Point”) a Greenwich-based private investment firm focused exclusively on the health care industry, announced today that it was again recognized on Inc.’s Founder-Friendly Investors list. This list honors the private equity, venture capital, and debt firms with track records of successfully partnering with the founder-led businesses they invest in, while maintaining their entrepreneurial spirit. This marks the third consecutive yea...

Eutecma Announces Kevin Grogan as Chief Executive Officer to Lead Global Operations and Expansion

MANNHEIM, Germany & SPRINGFIELD, Ohio--(BUSINESS WIRE)--Eutecma (or “the Company”), a German-based developer of sustainable, modular, and reusable temperature controlled packaging solutions for pharmaceutical cold chain shipments, today announced the appointment of Kevin Grogan as Chief Executive Officer to lead the Company’s global operations and expansion. Mr. Grogan has nearly thirty years of industry expertise in pharmaceutical, healthcare and foodservice packaging solutions across North Am...
Back to Newsroom